{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:47:20Z","timestamp":1789915640648,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 AI116472-03"],"award-info":[{"award-number":["R01 AI116472-03"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013885","name":"Ministry of Health Malaysia","doi-asserted-by":"publisher","award":["BP00500420"],"award-info":[{"award-number":["BP00500420"]}],"id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1037304"],"award-info":[{"award-number":["1037304"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156809"],"award-info":[{"award-number":["1156809"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016396"],"award-info":[{"award-number":["2016396"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2017436"],"award-info":[{"award-number":["2017436"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016792"],"award-info":[{"award-number":["2016792"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1045156"],"award-info":[{"award-number":["1045156"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.isci.2025.112768","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:46:02Z","timestamp":1748371562000},"page":"112768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteoprotegerin and its ligands RANKL and TRAIL in falciparum, vivax, and knowlesi malaria"],"prefix":"10.1016","volume":"28","author":[{"given":"Arya Sheela","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Loughland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Piera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Amante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-7960","authenticated-orcid":false,"given":"Bridget E.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112768_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112768_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112768_bib3","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/hq1201.100229","article-title":"Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques","volume":"21","author":"Dhore","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.isci.2025.112768_bib4","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-\u03baB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Collin-Osdoby","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.112768_bib5","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","article-title":"OPG\/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40","volume":"161","author":"Yun","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.112768_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/564934","article-title":"Osteoprotegerin in cardiometabolic disorders","volume":"2015","author":"P\u00e9rez de Ciriza","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.isci.2025.112768_bib7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10741-021-10153-2","article-title":"Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases","volume":"27","author":"Dutka","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.isci.2025.112768_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/ijms20030705","article-title":"The role of osteoprotegerin and its ligands in vascular function","volume":"20","author":"Rochette","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.112768_bib9","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1084\/jem.20070819","article-title":"Impaired nitric oxide bioavailability and L-arginine\u2013reversible endothelial dysfunction in adults with falciparum malaria","volume":"204","author":"Yeo","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2025.112768_bib10","first-page":"106","article-title":"Intravascular haemolysis in severe Plasmodium knowlesi malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury","volume":"7","author":"Barber","year":"2018","journal-title":"inges Infect."},{"key":"10.1016\/j.isci.2025.112768_bib11","series-title":"World Malaria Report 2024","year":"2024"},{"key":"10.1016\/j.isci.2025.112768_bib12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/infdis\/jix193","article-title":"Effects of aging on parasite biomass, inflammation, endothelial activation, microvascular dysfunction and disease severity in Plasmodium knowlesi and Plasmodium falciparum malaria","volume":"215","author":"Barber","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2025.112768_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/cis902","article-title":"A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy","volume":"56","author":"Barber","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2025.112768_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004558","article-title":"Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria","volume":"11","author":"Barber","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112768_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aam8093","article-title":"Plasmodium products persist in the bone marrow and promote chronic bone loss","volume":"2","author":"Lee","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2025.112768_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00895-19","article-title":"Early endothelial activation precedes glycocalyx degradation and microvascular dysfunction in experimentally induced Plasmodium falciparum and Plasmodium vivax infection","volume":"88","author":"Woodford","year":"2020","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.112768_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1160\/TH15-10-0796","article-title":"Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria","volume":"115","author":"O\u2019Regan","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.isci.2025.112768_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cardiores.2007.07.017","article-title":"Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-\u03b1 associated with induction of angiopoietin-2","volume":"76","author":"Mangan","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.isci.2025.112768_bib19","doi-asserted-by":"crossref","first-page":"17097","DOI":"10.1073\/pnas.0805782105","article-title":"Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria","volume":"105","author":"Yeo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112768_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12916-015-0365-9","article-title":"Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: an observational study","volume":"13","author":"Hanson","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2025.112768_bib21","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.4049\/jimmunol.177.6.3799","article-title":"Receptor activator of NF-\u03baB ligand and osteoprotegerin regulate proinflammatory cytokine production in mice","volume":"177","author":"Maruyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.112768_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pt.2024.04.015","article-title":"The biology and pathogenesis of vivax malaria","volume":"40","author":"Anstey","year":"2024","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.isci.2025.112768_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1086\/653211","article-title":"Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia","volume":"202","author":"Yeo","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2025.112768_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.freeradbiomed.2018.08.031","article-title":"TRAIL protects against endothelial dysfunction in vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in vitro","volume":"126","author":"Manuneedhi Cholan","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.isci.2025.112768_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biocel.2016.09.019","article-title":"Redox signaling and oxidative stress: cross talk with TNF-related apoptosis inducing ligand activity","volume":"81","author":"Voltan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.isci.2025.112768_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002527","article-title":"Tumor Necrosis Factor\u2013Related Apoptosis-Inducing Ligand (TRAIL) promotes angiogenesis and ischemia-induced neovascularization via NADPH oxidase 4 (NOX4) and nitric oxide\u2013dependent mechanisms","volume":"4","author":"Di Bartolo","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.isci.2025.112768_bib27","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.112768_bib28","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","article-title":"B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo","volume":"109","author":"Li","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.112768_bib29","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2008-03-146779","article-title":"Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen","volume":"112","author":"Safeukui","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.112768_bib30","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMc2023884","article-title":"Hidden biomass of intact malaria parasites in the human spleen","volume":"384","author":"Kho","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112768_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2003.09.001","article-title":"Regulatory effects of osteoprotegerin on cellular and humoral immune responses","volume":"109","author":"Stolina","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.isci.2025.112768_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/tmi.12313_2","article-title":"Severe Malaria","volume":"19","year":"2014","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.isci.2025.112768_bib33","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1093\/cid\/ciaa368","article-title":"A Phase 1, placebo-controlled, randomized, single ascending dose study and a volunteer infection study to characterize the safety, pharmacokinetics, and antimalarial activity of the Plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048","volume":"71","author":"McCarthy","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2025.112768_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01371-19","article-title":"A single-dose combination study with the experimental antimalarials artefenomel and DSM265 to determine safety and antimalarial activity against blood-stage Plasmodium falciparum in healthy volunteers","volume":"64","author":"McCarthy","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.112768_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01896-19","article-title":"Safety, tolerability, pharmacokinetics, and antimalarial activity of the novel Plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048 in healthy volunteers","volume":"64","author":"Sinxadi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.112768_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01837-18","article-title":"DSM265 at 400 milligrams clears asexual stage parasites but not mature gametocytes from the blood of healthy subjects experimentally infected with Plasmodium falciparum","volume":"63","author":"Collins","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.112768_bib37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/infdis\/jiaa287","article-title":"Antimalarial activity of artefenomel against asexual parasites and transmissible gametocytes during experimental blood-stage Plasmodium vivax infection","volume":"225","author":"Collins","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2025.112768_bib38","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1172\/JCI134923","article-title":"A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions","volume":"130","author":"Collins","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.isci.2025.112768_bib39","doi-asserted-by":"crossref","DOI":"10.5395\/rde.2024.49.e21","article-title":"An elaboration on sample size determination for correlations based on effect sizes and confidence interval width: a guide for researchers","volume":"49","author":"Bujang","year":"2024","journal-title":"Restor. Dent. Endod."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225010296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225010296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:22:32Z","timestamp":1778901752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225010296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589004225010296"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112768","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoprotegerin and its ligands RANKL and TRAIL in falciparum, vivax, and knowlesi malaria","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112768"}}